메뉴 건너뛰기




Volumn 323, Issue 1, 2007, Pages 318-326

Blockade of cannabinoid type 1 receptors augments the antiparkinsonian action of levodopa without affecting dyskinesias in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-treated rhesus monkeys

Author keywords

[No Author keywords available]

Indexed keywords

1 [7 (2 CHLOROPHENYL) 8 (4 CHLOROPHENYL) 2 METHYLPYRAZOLO[1,5 A][1,3,5] TRIAZIN 4 YL] 3 ETHYLAMINOAZETIDINE 3 CARBOXYLIC ACID AMIDE BENZENESULFONATE; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 AMINOBUTYRIC ACID; BENSERAZIDE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CARBIDOPA PLUS LEVODOPA; GLUTAMIC ACID; LEVODOPA; UNCLASSIFIED DRUG;

EID: 34548848043     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.125666     Document Type: Article
Times cited : (90)

References (42)
  • 2
    • 0030656298 scopus 로고    scopus 로고
    • Simultaneous determination of L-dopa and 3-O-methyldopa in human platelets and plasma using high-performance liquid chromatography with electrochemical detection
    • Blandini F, Martignoni E, Pacchetti C, Desideri S, Rivellini D, and Nappi G (1997) Simultaneous determination of L-dopa and 3-O-methyldopa in human platelets and plasma using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Sci Appl 700:278-282.
    • (1997) J Chromatogr B Biomed Sci Appl , vol.700 , pp. 278-282
    • Blandini, F.1    Martignoni, E.2    Pacchetti, C.3    Desideri, S.4    Rivellini, D.5    Nappi, G.6
  • 3
    • 0031739073 scopus 로고    scopus 로고
    • Adjuncts to dopamine replacement: A pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease
    • Brotchie JM (1998) Adjuncts to dopamine replacement: a pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease. Mov Disord 13:871-876.
    • (1998) Mov Disord , vol.13 , pp. 871-876
    • Brotchie, J.M.1
  • 4
    • 0347379832 scopus 로고    scopus 로고
    • Cannabinoids decrease corticostriatal synaptic transmission via an effect on glutamate uptake
    • Brown TM, Brotchie JM, and Fitzjohn SM (2003) Cannabinoids decrease corticostriatal synaptic transmission via an effect on glutamate uptake. J Neurosci 23:11073-11077.
    • (2003) J Neurosci , vol.23 , pp. 11073-11077
    • Brown, T.M.1    Brotchie, J.M.2    Fitzjohn, S.M.3
  • 5
    • 0034105156 scopus 로고    scopus 로고
    • Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications
    • discussion S129-S130
    • Chase TN and Oh JD (2000) Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications. Ann Neurol 47:S122-S129; discussion S129-S130.
    • (2000) Ann Neurol , vol.47
    • Chase, T.N.1    Oh, J.D.2
  • 6
    • 0033936028 scopus 로고    scopus 로고
    • Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease
    • Di Marzo V, Hill MP, Bisogno T, Crossman AR, and Brotchie JM (2000) Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. FASEB J 14:1432-1438.
    • (2000) FASEB J , vol.14 , pp. 1432-1438
    • Di Marzo, V.1    Hill, M.P.2    Bisogno, T.3    Crossman, A.R.4    Brotchie, J.M.5
  • 7
    • 0032401036 scopus 로고    scopus 로고
    • Endocannabinoids: Endogenous cannabinoid receptor ligands with neuromodulatory action
    • Di Marzo V, Melck D, Bisogno T, and De Petrocellis L (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 21:521-528.
    • (1998) Trends Neurosci , vol.21 , pp. 521-528
    • Di Marzo, V.1    Melck, D.2    Bisogno, T.3    De Petrocellis, L.4
  • 9
    • 0141481993 scopus 로고    scopus 로고
    • Effects of levodopa on endocannabinoid levels in rat basal ganglia: Implications for the treatment of levodopa-induced dyskinesias
    • Ferrer B, Asbrock N, Kathuria S, Piomelli D, and Giuffrida A (2003) Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias. Eur J Neurosci 18:1607-1614.
    • (2003) Eur J Neurosci , vol.18 , pp. 1607-1614
    • Ferrer, B.1    Asbrock, N.2    Kathuria, S.3    Piomelli, D.4    Giuffrida, A.5
  • 10
    • 0036868444 scopus 로고    scopus 로고
    • Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease
    • Fox SH, Henry B, Hill M, Crossman A, and Brotchie J (2002) Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease. Mov Disord 17:1180-1187.
    • (2002) Mov Disord , vol.17 , pp. 1180-1187
    • Fox, S.H.1    Henry, B.2    Hill, M.3    Crossman, A.4    Brotchie, J.5
  • 11
    • 0035176184 scopus 로고    scopus 로고
    • CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum
    • Gerdeman G and Lovinger DM (2001) CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J Neurophysiol 85:468-471.
    • (2001) J Neurophysiol , vol.85 , pp. 468-471
    • Gerdeman, G.1    Lovinger, D.M.2
  • 12
    • 0036233834 scopus 로고    scopus 로고
    • Postsynaptic endocannabinoid release is critical to long-term depression in the striatum
    • Gerdeman GL, Ronesi J, and Lovinger DM (2002) Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci 5:446-451.
    • (2002) Nat Neurosci , vol.5 , pp. 446-451
    • Gerdeman, G.L.1    Ronesi, J.2    Lovinger, D.M.3
  • 14
    • 34548818911 scopus 로고    scopus 로고
    • Inventor; Pfizer, Inc., assignee. Cannabinoid receptor ligands and uses thereof
    • U.S. Patent 7,176,210, Feb 13
    • Griffith DA (2007), Inventor; Pfizer, Inc., assignee. Cannabinoid receptor ligands and uses thereof. U.S. Patent 7,176,210. 2007 Feb 13.
    • (2007)
    • Griffith, D.A.1
  • 15
    • 0344052684 scopus 로고    scopus 로고
    • Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys
    • Grondin R, Bedard PJ, Hadj Tahar A, Gregoire L, Mori A, and Kase H (1999) Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys. Neurology 52:1673-1677.
    • (1999) Neurology , vol.52 , pp. 1673-1677
    • Grondin, R.1    Bedard, P.J.2    Hadj Tahar, A.3    Gregoire, L.4    Mori, A.5    Kase, H.6
  • 17
    • 0037041286 scopus 로고    scopus 로고
    • Comparison of the basal ganglia in rats, marmosets, macaques, baboons, and humans: Volume and neuronal number for the output, internal relay, and striatal modulating nuclei
    • Hardman CD, Henderson JM, Finkelstein DI, Horne MK, Paxinos G, and Halliday GM (2002) Comparison of the basal ganglia in rats, marmosets, macaques, baboons, and humans: volume and neuronal number for the output, internal relay, and striatal modulating nuclei. J Comp Neurol 445:238-255.
    • (2002) J Comp Neurol , vol.445 , pp. 238-255
    • Hardman, C.D.1    Henderson, J.M.2    Finkelstein, D.I.3    Horne, M.K.4    Paxinos, G.5    Halliday, G.M.6
  • 19
    • 0037074929 scopus 로고    scopus 로고
    • Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain
    • Hermann H, Marsicano G, and Lutz B (2002) Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience 109:451-460.
    • (2002) Neuroscience , vol.109 , pp. 451-460
    • Hermann, H.1    Marsicano, G.2    Lutz, B.3
  • 20
    • 0003633755 scopus 로고    scopus 로고
    • Institute of Laboratory Animal Resources , 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC
    • Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
    • (1996) Guide for the Care and Use of Laboratory Animals
  • 21
    • 33846908287 scopus 로고    scopus 로고
    • Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models
    • Kreitzer AC and Malenka RC (2007) Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 445:643-647.
    • (2007) Nature , vol.445 , pp. 643-647
    • Kreitzer, A.C.1    Malenka, R.C.2
  • 22
    • 0035545362 scopus 로고    scopus 로고
    • Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets
    • Lastres-Becker I, Cebeira M, de Ceballos ML, Zeng BY, Jenner P, Ramos JA, and Fernandez-Ruiz JJ (2001) Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets. Eur J Neurosci 14:1827-1832.
    • (2001) Eur J Neurosci , vol.14 , pp. 1827-1832
    • Lastres-Becker, I.1    Cebeira, M.2    de Ceballos, M.L.3    Zeng, B.Y.4    Jenner, P.5    Ramos, J.A.6    Fernandez-Ruiz, J.J.7
  • 24
    • 0027482872 scopus 로고
    • Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: An in situ hybridization study
    • Mailleux P and Vanderhaeghen JJ (1993) Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study. J Neurochem 61:1705-1712.
    • (1993) J Neurochem , vol.61 , pp. 1705-1712
    • Mailleux, P.1    Vanderhaeghen, J.J.2
  • 25
    • 0030592139 scopus 로고    scopus 로고
    • Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus
    • Maneuf YP, Nash JE, Crossman AR, and Brotchie JM (1996) Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus. Eur J Pharmacol 308:161-164.
    • (1996) Eur J Pharmacol , vol.308 , pp. 161-164
    • Maneuf, Y.P.1    Nash, J.E.2    Crossman, A.R.3    Brotchie, J.M.4
  • 26
    • 0034008670 scopus 로고    scopus 로고
    • D(2), but not D(1) dopamine receptor agonists potentiate cannabinoid-induced sedation in nonhuman primates
    • Meschler JP, Clarkson FA, Mathews PJ, Howlett AC, and Madras BK (2000a) D(2), but not D(1) dopamine receptor agonists potentiate cannabinoid-induced sedation in nonhuman primates. J Pharmacol Exp Ther 292:952-959.
    • (2000) J Pharmacol Exp Ther , vol.292 , pp. 952-959
    • Meschler, J.P.1    Clarkson, F.A.2    Mathews, P.J.3    Howlett, A.C.4    Madras, B.K.5
  • 27
    • 0034495021 scopus 로고    scopus 로고
    • Cannabinoid and dopamine interaction in rodent brain: Effects on locomotor activity
    • Meschler JP, Conley TJ, and Howlett AC (2000b) Cannabinoid and dopamine interaction in rodent brain: effects on locomotor activity. Pharmacol Biochem Behav 67:567-573.
    • (2000) Pharmacol Biochem Behav , vol.67 , pp. 567-573
    • Meschler, J.P.1    Conley, T.J.2    Howlett, A.C.3
  • 28
    • 0034942985 scopus 로고    scopus 로고
    • Cannabinoid receptor agonist and antagonist effects on motor function in normal and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-treated non-human primates
    • Meschler JP, Howlett AC, and Madras BK (2001) Cannabinoid receptor agonist and antagonist effects on motor function in normal and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-treated non-human primates. Psychopharmacology 156:79-85.
    • (2001) Psychopharmacology , vol.156 , pp. 79-85
    • Meschler, J.P.1    Howlett, A.C.2    Madras, B.K.3
  • 30
    • 0030246850 scopus 로고    scopus 로고
    • Effect of MK 801 on priming of D1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen
    • Morelli M, Fenu S, Carta A, and Di Chiara G (1996) Effect of MK 801 on priming of D1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen. Behav Brain Res 79:93-100.
    • (1996) Behav Brain Res , vol.79 , pp. 93-100
    • Morelli, M.1    Fenu, S.2    Carta, A.3    Di Chiara, G.4
  • 31
    • 0034027839 scopus 로고    scopus 로고
    • Clinical pharmacology of levodopa-induced dyskinesia
    • discussion S164-S166
    • Nutt JG (2000) Clinical pharmacology of levodopa-induced dyskinesia. Ann Neurol 47:S160-S164; discussion S164-S166.
    • (2000) Ann Neurol , vol.47
    • Nutt, J.G.1
  • 32
    • 0035225372 scopus 로고    scopus 로고
    • Fluctuations in response to treatment for Parkinson's disease
    • Nutt JG (2001) Fluctuations in response to treatment for Parkinson's disease. Adv Neurol 86:361-366.
    • (2001) Adv Neurol , vol.86 , pp. 361-366
    • Nutt, J.G.1
  • 33
    • 0029883235 scopus 로고    scopus 로고
    • The response to levodopa in Parkinson's disease: Imposing pharmacological law and order
    • Nutt JG and Holford NH (1996) The response to levodopa in Parkinson's disease: imposing pharmacological law and order. Ann Neurol 39:561-573.
    • (1996) Ann Neurol , vol.39 , pp. 561-573
    • Nutt, J.G.1    Holford, N.H.2
  • 34
    • 0033695441 scopus 로고    scopus 로고
    • Levodopa motor complications in Parkinson's disease
    • Obeso JA, Olanow CW, and Nutt JG (2000) Levodopa motor complications in Parkinson's disease. Trends Neurosci 23:S2-S7.
    • (2000) Trends Neurosci , vol.23
    • Obeso, J.A.1    Olanow, C.W.2    Nutt, J.G.3
  • 35
    • 9144274541 scopus 로고    scopus 로고
    • Prolongation of levodopa responses by glycine B antagonists in parkinsonian primates
    • Papa SM, Auberson YP, and Greenamyre JT (2004) Prolongation of levodopa responses by glycine B antagonists in parkinsonian primates. Ann Neurol 56:723-727.
    • (2004) Ann Neurol , vol.56 , pp. 723-727
    • Papa, S.M.1    Auberson, Y.P.2    Greenamyre, J.T.3
  • 36
    • 0029665122 scopus 로고    scopus 로고
    • Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys
    • Papa SM and Chase TN (1996) Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys. Ann Neurol 39:574-578.
    • (1996) Ann Neurol , vol.39 , pp. 574-578
    • Papa, S.M.1    Chase, T.N.2
  • 37
    • 0029417121 scopus 로고
    • Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-treated common marmoset (Callithrix jacchus)
    • Pearce RK, Jackson M, Smith L, Jenner P, and Marsden CD (1995) Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-treated common marmoset (Callithrix jacchus). Mov Disord 10:731-740.
    • (1995) Mov Disord , vol.10 , pp. 731-740
    • Pearce, R.K.1    Jackson, M.2    Smith, L.3    Jenner, P.4    Marsden, C.D.5
  • 39
    • 0035846577 scopus 로고    scopus 로고
    • Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: A pilot study
    • Sieradzan KA, Fox SH, Hill M, Dick JP, Crossman AR, and Brotchie JM (2001) Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study. Neurology 57:2108-2111.
    • (2001) Neurology , vol.57 , pp. 2108-2111
    • Sieradzan, K.A.1    Fox, S.H.2    Hill, M.3    Dick, J.P.4    Crossman, A.R.5    Brotchie, J.M.6
  • 40
    • 0034117096 scopus 로고    scopus 로고
    • Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata
    • Szabo B, Wallmichrath I, Mathonia P, and Pfreundtner C (2000) Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata. Neuroscience 97:89-97.
    • (2000) Neuroscience , vol.97 , pp. 89-97
    • Szabo, B.1    Wallmichrath, I.2    Mathonia, P.3    Pfreundtner, C.4
  • 41
    • 21744461614 scopus 로고    scopus 로고
    • A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease
    • van der Stelt M, Fox SH, Hill M, Crossman AR, Petrosino S, Di Marzo V, and Brotchie JM (2005) A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease. FASEB J 19:1140-1142.
    • (2005) FASEB J , vol.19 , pp. 1140-1142
    • van der Stelt, M.1    Fox, S.H.2    Hill, M.3    Crossman, A.R.4    Petrosino, S.5    Di Marzo, V.6    Brotchie, J.M.7
  • 42
    • 0037008878 scopus 로고    scopus 로고
    • Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse
    • Wallmichrath I and Szabo B (2002) Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse. Neuroscience 113:671-682.
    • (2002) Neuroscience , vol.113 , pp. 671-682
    • Wallmichrath, I.1    Szabo, B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.